Market Tracker

06/30 8:28am ET

Vanguard Mid-Cap Index Fund ETF Shares (VO)

126.79
Delayed Data
As of Jun 29
 -2.82 / -2.18%
Today’s Change
107.89
Today|||52-Week Range
132.70
+2.61%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Mid Cap Index, a broadly diversified index of stocks of mid-size U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Performance

1 month-2.20% 3 years+19.52%
3 months-0.95% 5 years+17.94%
1 year+8.45% Since inception+9.84%
Data through 06/30/2015

Quote Details

Previous close$129.61
Open day’s range-- – --
Net asset value (NAV)126.75 (06/29/2015)
Daily volume514,988
Average volume (3 months)313,577
Data as of 06/29/2015

Peer Comparisonvs. Mid-cap blend ETFs

 VOCategory
Performance 5-yr return+17.94%+15.76%
Expense Gross exp ratio0.09%0.44%
Risk 5 year sharpe ratio1.181.10
Net assets$66.3B$2.9B
Average market cap$11.5B$7.8B
Average P/E21.720.2
Dividend / Share--0.24%

Competitors

EQWM PowerShares Russell Midcap Equal Weight ...
IWR iShares Russell Mid-Cap ETF
TILT FlexShares Morningstar US Market Factors...

Holdings

Top 5 Sectors
Portfolio weighting
Financial service 17.05%
Industrial materials 14.95%
Consumer goods 10.54%
Consumer service 9.84%
Energy 9.79%
Top 10 Holdings
Portfolio weighting
DLPH Delphi Automotive PLC0.75%
BSX Boston Scientific Corp0.73%
ABC AmerisourceBergen Corp0.70%
AVB AvalonBay Communities0.66%
MCO Moody's Corp0.65%
ORLY O'Reilly Automotive Inc0.63%
SWKS Skyworks Solutions Inc0.62%
CERN Cerner Corp0.62%
BMRN Biomarin Pharmaceutical Inc0.59%
MNST Monster Beverage Corp0.57%